MENU

ILMN Stock Illumina (ILMN, $92.19) price may climb as it broke lower Bollinger Band on Sep 25, 2025

A.I.dvisor
at Tickeron.com
Loading...
ILMN - Illumina
Bollinger signal
Bullish Trend
Odds of UP Trend
Tickeron
Bollinger signal
Price: $92.19
Daily change: -$2.22 (-2.35%)
Daily volume: 2M
Capitalization: $14.2B
Industry: Medical Specialties
This price move could be a signal that ILMN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. A.I.dvisor backtested 47 similar cases where ILMN's price broke its lower Bollinger Band, and of them led to a successful outcome. Odds of Success:

ILMN sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for ILMN moved above the 200-day moving average on September 26, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ILMN just turned positive on October 03, 2025. Looking at past instances where ILMN's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

ILMN moved above its 50-day moving average on October 03, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ILMN advanced for three days, in of 281 cases, the price rose further within the following month. The odds of a continued upward trend are .

ILMN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Momentum Indicator moved below the 0 level on October 02, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ILMN as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 10-day moving average for ILMN crossed bearishly below the 50-day moving average on September 25, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ILMN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ILMN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.949) is normal, around the industry mean (9.455). P/E Ratio (12.570) is within average values for comparable stocks, (136.052). Projected Growth (PEG Ratio) (0.617) is also within normal values, averaging (1.777). ILMN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (3.778) is also within normal values, averaging (9.153).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ILMN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
ILMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ILMN showed earnings on July 31, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a manufacturer of integrated systems for the analysis of genetic variation and function

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
5200 Illumina Way
Phone
+1 858 202-4500
Employees
10670
Web
https://www.illumina.com